Categories
Articles

The UK drugs giant AstraZeneca wants its US rival Gilead to consider a merger

Business Insider Feedburner

Categories
Articles

The $95 billion biotech Gilead just announced plans to test a promising potential coronavirus treatment in 1,000 people (GILD)

Business Insider Feedburner